Ultra-hypofractionated SBRT has low acute toxicity in localized prostate cancer
medwireNews,
08-10-2019 | Oncology | News | Article medwireNews: Ultra-hypofractionated stereotactic body radiotherapy (SBRT) does not…
08-10-2019 | Oncology | News | Article medwireNews: Ultra-hypofractionated stereotactic body radiotherapy (SBRT) does not…
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for September 2019.
Here are what the editors at HealthDay consider to be the most important developments in Radiology for September 2019.
(HealthDay News) — A targeted radiotherapy technique can substantially cut treatment time for prostate cancer without…